Jump to main content


Research articles

  1. Sazhnev V, DeKrey GK.  The growth and infectivity of Leishmania major is not altered by in vitro exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin.  BMC Res Notes (2018) 11:642.  doi: 10.1186/s13104-018-3759-x.  PMID:  PDF reprint.
  2. Terry AI, Benitez-Kruidenier S, DeKrey GK. Effects of endosulfan isomers on cytokine and nitric oxide production by differentially activated RAW 264.7 cells. Toxicology Reports (2018) Mar 7; 5:396-400. doi: 10.1016/j.toxrep.2018.03.006. PMID: 29765866. PDF reprint.
  3. Worley SL, Vaughn BJ, Terry AI, Gardiner CS, DeKrey GK. Time- and dose-dependent effects of ethanol on mouse embryonic stem cells. Reproductive Toxicology (2015) Nov; 57:157-64.  PDF reprint.
  4. DeKrey GK, Teagarden RE, Lenberg JL, RG Titus. 2,3,7,8-Tetrachlorodibenzo-p-dioxin slows the progression of experimental cutaneous leishmaniasis in susceptible BALB/c and SCID mice. PLOS One (2013), 8(10):e76259.  PDF reprint.
  5. Peichoto ME, Tavares FL, DeKrey GK, Mackessy SP. Comparative studies of the effects of venoms from five rear-fanged snake species on the growth of Leishmania major. Toxicon (2011), 58(1): 28-34.  PDF reprint.
  6. Casabar, RCT, PC Das, GK DeKrey, CS Gardiner, Y Cao, RL Rose, and AD Wallace. Endosulfan induces CYP2B6 and CYP3A4 by activating the pregnane X receptor. Toxicology and Applied Pharmacology (2010), 245 (3): 335-343.  PDF reprint.
  7. Bowers, OJ, KB Sommersted, RT Sowell, GE Boling, WH Hanneman, RG Titus, GK DeKrey. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) reduces Leishmania major burdens in C57Bl/6 Mice. American Journal of Tropical Medicine and Hygiene (2006), 75: 749-752.  PDF reprint.
  8. Hausburg, MA, GK DeKrey, JJ Salmen, MR Palic, CS Gardiner. Effects of paraquat on development of preimplantation embryos in vivo and in vitro. Reproductive Toxicology (2005), 20: 239-246.  PDF reprint.
  9. DeKrey, GK, J Jones, ML Mbow, CI Brodskyn, RG Titus. B cells are required for delayed type hypersensitivity-like pathology after secondary infection with Leishmania major in resistant C57B1/6 mice. Journal of Tropical Medicine and Hygiene (2003), 69: 481-483.  PDF reprint.
  10. Rogers, K, GK DeKrey, ML Mbow, RD Gillespie, CI Brodskyn, RG Titus. Type 1 and type 2 responses to Leishmania major. FEMS Microbiology Letters (2002), 10360: 1-7.  PDF reprint.
  11. Mbow, ML, GK DeKrey, RG Titus. Leishmania major induces differential expression of costimulatory molecules on mouse epidermal cells. European Journal of Immunology (2001), 31(5): 1400-9.  PDF reprint.
  12. Titus, RG, GK DeKrey, M Suares, R Morris. Interleukin-6-deficiency influences cytokine expression in susceptible BALB mice infected with Leishmania major but does not alter the outcome of disease. Infection and Immunity (2001), 69: 5189-5192.  PDF reprint
  13. Brodskyn, CI, GK DeKrey, RG Titus, Influence of costimulatory molecules on the immune response to Leishmania major by human cells in vitro. Infection and Immunity (2001), 69(2): 665-72.  PDF reprint.
  14. DeKrey, GK, RG Titus. A method for isolation and analysis of leucocytic cells from leishmanial ear lesions in mice. Journal of Immunological Methods (1999), 228(1-2): 1-11.  PDF reprint.
  15. Lima, HC, GK DeKrey, RG Titus. Leishmania braziliensis: Resolution of infection with this parasite confers complete protection to a subsequent challenge with L. major in BALB/c mice. Memórias do Instituto Oswaldo Cruz (1999), 94(1): 71-76.  PDF reprint.
  16. DeKrey, GK, Lima, HC, RG Titus. Analysis of the immune response of mice to infection with Leishmania braziliensis. Infection and Immunity (1998), 66(2): 827-929.  PDF reprint.
  17. Kerkvliet, NI, L Baecher-Steppan, DM Shepherd, JA Oughton, BA Vorderstrasse, GK DeKrey. Inhibition of TC-1 cytokine production, effector cytotoxic T lymphocyte development and alloantibody production by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Journal of Immunology (1996), 157(6): 2310-2319.  PDF reprint.
  18. Oughton, JA, CB Pereira, GK DeKrey, JM Collier, AA Frank, NI Kerkvliet. Phenotypic analysis of spleen, thymus, and peripheral blood cells in aged C57Bl/6 mice following long-term exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Fundamental and Applied Toxicology (1995), 25(1): 60-69.  PDF reprint.
  19. De Krey, GK, NI Kerkvliet. Suppression of cytotoxic T lymphocyte activity by 2,3,7,8-tetrachlorodibenzo-p-dioxin occurs in vivo, but not in vitro, and is independent of corticosterone elevation. Toxicology (1995), 97(1-3): 105-112.  PDF reprint.
  20. DeKrey, GK, NI Kerkvliet. Effects of exogenous corticosterone treatment on alloantigen-specific cytotoxic T lymphocyte activity in mice. Journal of Pharmacology and Experimental Therapeutics (1995), 273(2): 823-829.  PDF reprint.
  21. De Krey, GK, NC Hollingshead, NI Kerkvliet, BB Smith. Suppression of prolactin and cytotoxic T lymphocyte activity in PCB-treated mice. International Journal of Immunopharmacology (1994), 16(3): 251-257.
  22. De Krey, GK, LB Baecher-Steppan, JR Fowles, NI Kerkvliet. Polychlorinated biphenyl-induced suppression of cytotoxic T lymphocyte activity: role of prostaglandin-E2. Toxicology Letters (1994), 74(3): 211-220.
  23. De Krey, GK, L Baecher-Steppan, JA Deyo, BB Smith, NI Kerkvliet. PCB-induced immune suppression: castration, but not adrenalectomy or RU 38486 treatment, partially restores the cytotoxic T lymphocyte response to alloantigen. Journal of Pharmacology and Experimental Therapeutics (1993), 267(1): 308-315.  PDF reprint.
  24. Feldkamp, SD, DP Costa, GK DeKrey. Energetics and behavioral effects of net entanglement on juvenile northern fur seals, Callorhinus ursinus. Fishery Bulletin (1988), 87: 85-94.  PDF reprint.

Book chapters

  1. Leyrer, J. M., Thomas, M. P., DeKrey, G. (2017) HPA Axis, Neuropeptides and
    Neuroimmune Regulation of Psychiatric Disorders. In Ikezu, T; Gendelman, H
    (Ed.), Neuroimmune Pharmacology (2nd ed., pp. 1814). Springer International